© Boston Life Sciences. 2012. All rights reserved. Important Legal Notice
Breaking News: Boston Life Sciences, Inc. Elects William L.S. Guinness to Its Board of Directors. more >
Boston Life Sciences Ends ALTROPANE(R) POET-1 Phase III Trial Early to Evaluate Full Data Set. more >
Boston Life Sciences Moves into New Headquarters. more >
Boston Life Sciences Announces $12.7 Million Private Placement of Common Stock. more >
Boston Life Sciences, Inc. is a Biotechnology Company Engaged in the Research and Clinical Development of Novel Diagnostic and Therapeutic Products for Central Nervous System Diseases.